Skip to main content

US ClosedU.S. Closed

RLAY: Relay Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials.

52W Range

86thpctl

Volume

0.78×avg

Market Cap

4.11BUSD

P/E Ratio

-12.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Relay Therapeutics, Inc.

RLAYNASDAQ Global Market·USD·Closed

Relay Therapeutics, Inc.

RLAYNASDAQ·USD·Closed

$18.77

−3.35%

$18.77

−$0.65 (3.35%)

52W Range

86thpctl

Volume

0.78×avg

Mkt Cap

4.11BUSD

P/E

-12.0TTM

Div Yield

–ann